Scientists in the San Francisco Bay Area identify nearly 200 potential drug targets
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost 100 years ago, offers limited protection and patients are becoming increasingly resistant to available drugs.
Despite this significant impact on humankind, very little is known about how tuberculosis develops and spreads in the body.
A group of researchers from the Gladstone Institutes, UC San Francisco (UCSF), and UC Berkeley used a systematic approach to get an entirely new look at the way tuberculosis infects people. Their study, published in the scientific journal Molecular Cell, uncovered interactions between tuberculosis and human proteins that could provide new approaches to combat infection.
“With a better understanding of the mechanisms used by tuberculosis to disrupt our immune response, we could eventually optimize vaccine strategies, as well as explore therapies to supplement antibiotics,” said Nevan J. Krogan, PhD, senior investigator at the Gladstone Institutes and director of the Quantitative Biosciences Institute at UCSF.
A New Way to Fight Tuberculosis
Tuberculosis is a complex disease, given that it’s caused by bacteria made up of 4,000 genes, as compared to viruses that generally have 10 or 15 genes. During infection, these genes produce approximately 100 proteins inside human cells. But until now, scientists knew virtually nothing about what these proteins do in the body.
Krogan, along with his colleague Jeffery S. Cox, PhD, from UC Berkeley, employed a mass spectrometry–based approach to identify interactions between tuberculosis proteins and human proteins.
“It’s the first time this approach has been applied to tuberculosis,” explained Cox, professor in molecular and cell biology and director of the Center for Emerging and Neglected Diseases at UC Berkeley. “Essentially, this technology works by placing a hook on the tuberculosis proteins. When we fish them out of the human cells, the human proteins to which they’re attached come with them, so we can see what they interact with.”
Using this method, the team of scientists targeted 34 tuberculosis proteins, very few of which had been studied before.
“We found 187 interactions between these tuberculosis proteins and human proteins,” said Krogan, who is also a professor of cellular and molecular pharmacology at UCSF. “Each one of those connections could ultimately represent a drug target—a new way to fight tuberculosis.”
One Connection Responds to Both Bacterial and Viral Infections
After their initial discovery, Krogan and Cox focused their attention on one specific connection. They studied the physical interaction between the human protein CBL and a tuberculosis protein called LpqN.
They showed that when they remove the LpqN protein, tuberculosis can’t infect human cells as well. However, when the CBL protein is also deleted, the tuberculosis infection can resume its regular growth. This suggests that CBL is involved in limiting bacterial infections.
“Interestingly, we discovered that when CBL is removed, cells also become more resistant to infections by viruses, such as herpes,” said Cox. “We believe that CBL acts as a switch to toggle between anti-bacterial and anti-viral responses in the cell. That’s why it’s important to study the interactions between proteins in an unbiased way; you never know what you’ll find!”
A Holistic View of Complex Problems
By studying how proteins interact and work together, scientists can begin to map proteins onto pathways and find unexpected connections. They can then compare the protein interactions across many pathogens and identify similarities.
To this end, Krogan and Cox recently founded the Host Pathogen Mapping Initiative with investigators from Gladstone, UCSF, UC Berkeley, and UC San Diego. Through this initiative, they will comprehensively map the gene and protein networks underlying infectious disease and develop technologies to lead to novel and targeted therapies.
The two scientists also helped launch the BioFulcrum Viral and Infectious Disease Research Program at Gladstone in 2017. The goal of this program is to develop host-directed therapies.
“Most therapies to fight infection currently target the virus or bacteria,” said Krogan. “But viruses and bacteria mutate quickly and develop resistance to existing treatments. Instead, we want to target human host proteins involved in common pathways. This could allow us to develop therapies that use a single drug to treat multiple pathogens.”
The scientists have already identified commonly hijacked pathways in human cells. The human genes hijacked by tuberculosis, for instance, are the same genes mutated in many other disease states, including cancer and autism.
Krogan added, “It’s about finding the cell’s Achilles’ heel, and targeting it to fight many diseases at once.”
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- 200 urged to get tuberculosis tests after Riverside City College student tests positive on January 11, 2019 at 7:37 pm
More than 200 students at Riverside City College should get tested for tuberculosis because a student has active tuberculosis, Riverside County health officials said Friday, Jan. 11. The student, who ... […]
- Riverside City College student diagnosed with active tuberculosis, health officials say on January 11, 2019 at 12:36 pm
A Riverside City College student on Friday was being treated for active tuberculosis, prompting health officials to issue a recommendation that anyone who may have come into contact with the ... […]
- Global Tuberculosis Vaccine Treatment Industry report details market developments such as key companies profile, market size by types and applications on January 10, 2019 at 12:29 pm
Global Tuberculosis Vaccine Treatment Market Size, Status and Forecast 2019-2025; the latest report focuses on current market status, estimated forecast, growth opportunities, key market and top playe... […]
- Bovine tuberculosis strain tested in B.C. cow is distinct, not seen in Canada on January 9, 2019 at 2:02 pm
OTTAWA—Canada’s chief veterinary officer says test results from a case of bovine tuberculosis found in a cow in British Columbia last November show a strain not seen before in Canada or the United Sta... […]
- ‘Pneumonia, Tuberculosis, Parasites’: Border Patrol Commissioner Details the Medical Needs at the Border on January 9, 2019 at 1:12 pm
While politicians in Washington, D.C., battle with each other over border wall funding, agents on the ground are facing an uphill medical battle trying to keep those waiting at the border healthy. […]
- RCSI researchers develop new tuberculosis treatment on January 8, 2019 at 8:04 am
Tuesday, 8 January 2019: Led by researchers at RCSI (Royal College of Surgeons in Ireland), a team of researchers has developed a new treatment for tuberculosis (TB). This work could offer a practical ... […]
- Irish-led researchers develop inhaler that helps treat tuberculosis on January 7, 2019 at 8:48 pm
Irish-based researchers have developed a new, practical treatment that could help tackle one of the world’s deadliest diseases. A team led by researchers from the Royal College of Surgeons in Ireland ... […]
- Irish-based researchers help make tuberculosis breakthrough on January 7, 2019 at 5:06 pm
A team of researchers led by Irish-based scientists has made a major breakthrough in tuberculosis treatment. The treatment is administered through an inhaler, and reduces the lung bacteria that causes ... […]
- Hunt for Hong Kong tuberculosis patient who bolted from isolation ward in Kowloon Hospital on January 5, 2019 at 4:26 am
The Hospital Authority is looking into how a tuberculosis patient under isolation was able to escape from his ward, Hong Kong’s health chief said. Secretary for Food and Health Sophia Chan Siu-chee sa... […]
via Bing News